Key result
Recombinant CSFV harboring amino acid substitutions W871T, W875D, and V878T in the E2 glycoprotein was completely attenuated in swine and protected animals against virulent challenge at 21 days.
Alteration of a putative fusion peptide in the E2 glycoprotein of classical swine fever virus attenuates the virus in swine and provides protection against wild-type challenge, offering a potential strategy for vaccine development.
This is the authors' abstract. We don't add key points for this paper.
E2, the major envelope glycoprotein of classical swine fever virus (CSFV), is involved in several critical virus functions, including cell attachment, host range susceptibility, and virulence in natural hosts. Functional structural analysis of E2 based on a Wimley-White interfacial hydrophobicity distribution predicted the involvement of a loop (residues 864 to 881) stabilized by a disulfide bond ( 869 CKWGGNWTCV 878 , named FPII) in establishing interactions with the host cell membrane. This loop further contains an 872 GG 873 dipeptide, as well as two aromatic residues ( 871 W and 875 W) accessible to solvent. Reverse genetics utilizing a full-length infectious clone of the highly virulent CSFV strain Brescia (BICv) was used to evaluate how amino acid substitutions within FPII may affect replication of BICv in vitro and virus virulence in swine. Recombinant CSFVs containing mutations in different residues of FPII were constructed. A particular construct, harboring amino acid substitutions W871T, W875D, and V878T (FPII.2), demonstrated a significantly decreased ability to replicate in a swine cell line (SK6) and swine macrophage primary cell cultures. Interestingly, mutated virus FPII.2 was completely attenuated in pigs. Also, animals infected with FPII.2 virus were protected against virulent challenge with Brescia virus at 21 days postvaccination. Supporting a role for the E2 the loop from residues 864 to 881 in membrane fusion, only synthetic peptides that were based on the native E2 functional sequence were competent for insertion into model membranes and perturbation of their integrity, and this functionality was lost in synthetic peptides harboring amino acid substitutions W871T, W875D, and V878T in FPII.2. IMPORTANCE This report describes the identification and characterization of a putative fusion peptide (FP) in the major structural protein E2 of classical swine fever virus (CSFV). The FP identification was performed by functional structural analysis of E2. We characterized the functional significance of this FP by using artificial membranes. Replacement of critical amino acid residues within the FP radically alters how it interacts with the artificial membranes. When we introduced the same mutations into the viral sequence, there was a reduction in replication in cell cultures, and when we infected domestic swine, the natural host of CSFV host, we observed that the virus was now completely attenuated in swine. In addition, the virus mutant that was attenuated in vivo efficiently protected pigs against wild-type virus. These results provide the proof of principle to support as a strategy for vaccine development the discovery and manipulation of FPs.
Answers are grounded in this paper and cite their sources.
May guide live-attenuated CSFV vaccine design; leaves open field efficacy and safety in swine.
No takes yet. Share an insight, caveat, or question.
Holinka et al. (2016) studied Classical swine fever virus (CSFV) infection. Recombinant CSFV with FPII mutations (W871T, W875D, V878T) vs. Wild-type Brescia virus (BICv) was evaluated on Virus replication in vitro and virulence in swine. Recombinant CSFV harboring amino acid substitutions W871T, W875D, and V878T in the E2 glycoprotein was completely attenuated in swine and protected animals against virulent challenge at 21 days.
Synapse has enriched 10 related papers. Consider them for comparative context: